RNS Number : 2857K
Integrated Diagnostics Holdings PLC
27 May 2025
 

Integrated Diagnostics Holdings plc

(the "Company")

 

Result of Annual General Meeting

27 May 2025

 

 

The Company announces that at the Annual General Meeting ("AGM") held today at the offices of Actis, 2 More London Riverside, London, SE1 2JT, all resolutions contained in the notice of the meeting, including two special resolutions were duly passed.  The special resolutions authorise the Company to allot shares on a non-pre-emptive basis and to make market purchases of Equity Securities in the capital of the Company. Each of the resolutions put to the AGM was voted on by way of a poll. The results of the poll for each resolution were as follows:

 

 

 

VOTES FOR

%

VOTES AGAINST

%

VOTES WITHHELD

TOTAL SHARES VOTED

1. To receive and consider the Company's Audited Financial Statements, together with the Reports of the Directors and the Auditor for the year ended 31 December 2024.

 

501,768,612

93.67

33,927,550

6.33

225

535,696,387

2. To re-elect Lord Anthony Tudor St John as a Director.

 

446,661,983

86.48

69,813,211

13.52

19,221,193

535,696,387

3. To re-elect Dr. Hend El-Sherbini as a Director.

 

484,973,873

93.9

31,501,321

6.1

19,221,193

535,696,387

4. To re-elect Sherif El Zeiny as a Director.

 

458,400,726

88.76

58,074,468

11.24

19,221,193

535,696,387

5. To re-elect Richard Henry Phillips as a Director.

 

446,661,983

86.48

69,813,211

13.52

19,221,193

535,696,387

6. To re-elect ~Dan Johan Wilmar Olsson as a Director.

 

440,599,372

87.29

64,137,079

12.71

30,959,936

535,696,387

7. To re-elect Hussein Hassan Choucri as a Director.

 

440,594,372

87.29

64,142,079

12.71

30,959,936

535,696,387

8. To re-elect Yvonne Stillhart as a Director.

 

473,235,130

93.76

31,501,321

6.24

30,959,936

535,696,387

9. To re-appoint PwC LLP as Auditor to hold office from the conclusion of this meeting until the conclusion of the next annual general meeting at which accounts are laid before the Company.

 

535,691,162

100

0

0

5,225

535,696,387

10. To authorise the Directors to determine the Auditor's remuneration.

 

516,475,194

100

0

0

19,221,193

535,696,387

11. Authority to issue and allot shares.

 

463,197,812

89.68

53,277,382

10.32

19,221,193

535,696,387

12. To hold shares as Treasury Shares.

 

484,971,300

93.9

31,503,894

6.1

19,221,193

535,696,387

13. To execute ancillary documents.

 

484,971,300

93.9

31,503,894

6.1

19,221,193

535,696,387

14. To authorise the Directors to dis-apply statutory pre-emption rights.

 

463,967,865

89.83

52,506,670

10.17

19,221,852

535,696,387

15.  Authority for the Company to make market purchases of its own shares.

 

516,466,962

99.99

7,573

0.01

19,221,852

535,696,387

 

 

Further information on the resolutions and the voting report will be available on the Company's website at https://investors.idhcorp.com/.

 

Copies of the resolutions passed as special resolutions at the AGM will shortly be available for inspection at the National Storage Mechanism, which is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

-Ends-

   

For further information please contact:

 

Integrated Diagnostics Holdings plc

 

 

Tarek Yehia

Investor Relations Director

tarek.yehia@idhcorp.com





Company Secretary

MUFG Corporate Governance Limited

IDHLondon@cm.mpms.mufg.com





 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSESFIWEISELI